Alternative transcripts and evidence of imprinting of GNAL on 18p11.2

Molecular Psychiatry

Volumn 10, Issue 11, 2005, Pages 1017-1025

  Corradi, J P ^a   Ravyn, V ^a   Robbins, A K ^a   Hagan, K W ^a   Peters, M F ^a   Bostwick, R ^a   Buono, R J ^b   Berrettini, W H ^b   Furlong, S T ^a  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CpG islands; Dopamine D1 receptor; G olf; G proteins; GPCRs

Indexed keywords

DOPAMINE 1 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEM; CHROMOSOME 18P; CONTROLLED STUDY; CPG ISLAND; EXON; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME IMPRINTING; GNAL GENE; METHYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; START CODON;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BIPOLAR DISORDER; CELL LINE; CENTRAL NERVOUS SYSTEM; CHROMOSOMES, HUMAN, PAIR 18; CPG ISLANDS; DNA METHYLATION; DNA, COMPLEMENTARY; EPIGENESIS, GENETIC; EXONS; FEMALE; GENOMIC IMPRINTING; GTP-BINDING PROTEIN ALPHA SUBUNITS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SCHIZOPHRENIA; SEQUENCE HOMOLOGY, AMINO ACID; SPODOPTERA; TRANSCRIPTION, GENETIC;

EID: 27544459833     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4001713     Document Type: Article

References (32)

1. Berrettini WH, Ferraro TN, Goldin LR, Weeks DE, Detera-Wadleigh S, Nurnberger Jr JI et al. Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc Natl Acad Sci USA 1994; 91: 5918-5921.
2. Stine OC, Xu J, Koskela R, McMahon FJ, Gschwend M, Friddle C et al. Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. Am J Hum Genet 1995; 57: 1384-1394.
3. Nothen MM, Cichon S, Rohleder H, Hemmer S, Franzek E, Fritze J et al. Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Mol Psychiatry 1999; 4: 76-84.
4. Schwab SG, Hallmayer J, Lerer B, Albus M, Borrmann M, Honig S et al. Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. Am J Hum Genet 1998; 63: 1139-1152.
5. Manji HK, Lenox RH. The nature of bipolar disorder. J Clin Psychiatry 2000; 61(Suppl 13): 42-57.
6. Miki M, Hamamura T, Ujike H, Lee Y, Habara T, Kodama M et al. Effects of subchronic lithium chloride treatment on G-protein subunits (Golf, Ggamma7) and adenylyl cyclase expressed specifically in the rat striatum. Eur J Pharmacol 2001; 428: 303-309.
7. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18: 1427-1431.
8. Vuoristo JT, Berrettini WH, Overhauser J, Prockop DJ, Ferraro TN, Ala-Kokko L. Sequence and genomic organization of the human G-protein Golfalpha gene (GNAL) on chromosome 18p11, a susceptibility region for bipolar disorder and schizophrenia. Mol Psychiatry 2000; 5: 495-501.
9. Kehlenbach RH, Matthey J, Huttner WB. XL alphas is a new type of G protein. Nature 1994; 372: 804-809.
10. Herve D, Rogard M, Levi-Strauss M. Molecular analysis of the multiple Golf alpha subunit mRNAs in the rat brain. Brain Res Mol Brain Res 1995; 32: 125-134.
11. Belluscio L, Gold GH, Nemes A, Axel R. Mice deficient in G(olf) are anosmic. Neuron 1998; 20: 69-81.
12. Zhuang X, Belluscio L, Hen R. G(olf) alpha mediates dopamine D1 receptor signaling. J Neurosci 2000; 20: RC91.
13. Corvol JC, Studler JM, Schonn JS, Girault JA, Herve D. Galpha(olf) is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum. J Neurochem 2001; 76: 1585-1588.
14. Hayward BE, Moran V, Strain L, Bonthron DT. Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins. Proc Natl Acad Sci USA 1998; 95: 15475-15480.
15. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826.
16. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000; 24: 132-138.
17. Ischia R, Lovisetti-Scamihorn P, Hogue-Angeletti R, Wolkersdorfer M, Winkler H, Fischer-Colbrie R. Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity. J Biol Chem 1997; 272: 11657-11662.
18. Weiss U, Ischia R, Eder S, Lovisetti-Scamihorn P, Bauer R, Fischer-Colbrie R. Neuroendocrine secretory protein 55 (NESP55): alternative splicing onto transcripts of the GNAS gene and posttranslational processing of a maternally expressed protein. Neuroendocrinology 2000; 71: 177-186.
19. Gille A, Seifert R. Co-expression of the beta2-adrenoceptor and dopamine D1-receptor with Gsalpha proteins in Sf9 insect cells: limitations in comparison with fusion proteins. Biochim Biophys Acta 2003; 1613: 101-114.
20. George SR, Lee SP, Varghese G, Zeman PR, Seeman P, Ng GY et al. A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. J Biol Chem 1998; 273: 30244-30248.
21. Leopoldt D, Harteneck C, Nurnberg B. G proteins endogenously expressed in Sf 9 cells: interactions with mammalian histamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 1997; 356: 216-224.
22. Herve D, Le Moine C, Corvol JC, Belluscio L, Ledent C, Fienberg AA et al. Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J Neurosci 2001; 21: 4390-4399.
23. Zahniser NR, Simosky JK, Mayfield RD, Negri CA, Hanania T, Larson GA et al. Functional uncoupling of adenosine A(2A) receptors and reduced response to caffeine in mice lacking dopamine D2 receptors. J Neurosci 2000; 20: 5949-5957.
24. Zhang D, Zhang L, Lou DW, Nakabeppu Y, Zhang J, Xu M. The dopamine D1 receptor is a critical mediator for cocaine-induced gene expression. J Neurochem 2002; 82: 1453-1464.
25. Weinstein LS, Yu S, Warner DR, Liu J. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev 2001; 22: 675-705.
26. Reik W, Walter J. Genomic imprinting: parental influence on the genome. Nat Rev Genet 2001; 2: 21-32.
27. Vuoristo JT, Ala-Kokko L. cDNA cloning, genomic organization and expression of the novel human metallophosphoesterase gene MPPE1 on chromosome 18p11.2. Cytogenet Cell Genet 2001; 95: 60-63.
28. Yoshikawa T, Kikuchi M, Saito K, Watanabe A, Yamada K, Shibuya H et al. Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples. Mol Psychiatry 2001; 6: 202-210.
29. Sjoholt G, Ebstein RP, Lie RT, Berle J, Mallet J, Deleuze JF et al. Examination of IMPA1 and IMPA2 genes in maniac-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder. Mol Psychiatry 2003; 23: 23.
30. Berrettini WH, Vuoristo J, Ferraro TN, Buono RJ, Wildenauer D, Ala-Kokko L. Human G(olf) gene polymorphisms and vulnerability to bipolar disorder. Psychiatr Genet 1998; 8: 235-238.
31. Tsiouris SJ, Breschel TS, Xu J, McInnis MG, McMahon FJ. Linkage disequilibrium analysis of G-olf alpha (GNAL) in bipolar affective disorder. Am J Med Genet 1996; 67: 491-494.
32. Zill P, Engel R, Baghai TC, Zwanzger P, Schule C, Minov C et al. Analysis of polymorphisms in the olfactory G-protein Golf in major depression. Psychiatr Genet 2002; 12: 17-22.